Ascendiant Capital Markets Forecasts Strong Price Appreciation for Pro-Dex (NASDAQ:PDEX) Stock
Pro-Dex (NASDAQ:PDEX – Get Free Report) had its price objective lifted by equities research analysts at Ascendiant Capital Markets from $54.00 to $56.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Ascendiant Capital Markets’ price objective suggests a potential upside of […]
Pro-Dex (NASDAQ:PDEX – Get Free Report) had its price objective lifted by equities research analysts at Ascendiant Capital Markets from $54.00 to $56.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Ascendiant Capital Markets’ price objective suggests a potential upside of […]
-logo-1200x675.png?v=20230920074015&w=240&h=240&zc=2){kind=logo}
